Pediatrix Medical Group Statistics
Total Valuation
MD has a market cap or net worth of $632.79 million. The enterprise value is $1.30 billion.
| Market Cap | 632.79M |
| Enterprise Value | 1.30B |
Important Dates
The next estimated earnings date is Thursday, August 1, 2024, before market open.
| Earnings Date | Aug 1, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
MD has 84.15 million shares outstanding. The number of shares has increased by 1.16% in one year.
| Shares Outstanding | 84.15M |
| Shares Change (YoY) | +1.16% |
| Shares Change (QoQ) | +2.39% |
| Owned by Insiders (%) | 1.60% |
| Owned by Institutions (%) | 105.72% |
| Float | 81.36M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 5.91 |
| PS Ratio | 0.32 |
| Forward PS | 0.30 |
| PB Ratio | 0.74 |
| P/FCF Ratio | 7.78 |
| PEG Ratio | 0.88 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 69.82, with an EV/FCF ratio of 15.93.
| EV / Earnings | n/a |
| EV / Sales | 0.65 |
| EV / EBITDA | 69.82 |
| EV / EBIT | n/a |
| EV / FCF | 15.93 |
Financial Position
The company has a current ratio of 1.73, with a Debt / Equity ratio of 0.91.
| Current Ratio | 1.73 |
| Quick Ratio | 1.61 |
| Debt / Equity | 0.91 |
| Debt / EBITDA | 41.95 |
| Debt / FCF | 9.57 |
| Interest Coverage | -0.45 |
Financial Efficiency
Return on equity (ROE) is -7.80% and return on invested capital (ROIC) is -0.42%.
| Return on Equity (ROE) | -7.80% |
| Return on Assets (ROA) | -3.10% |
| Return on Capital (ROIC) | -0.42% |
| Revenue Per Employee | $366,740 |
| Profits Per Employee | -$12,950 |
| Employee Count | 5,450 |
| Asset Turnover | 0.89 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, MD has paid $9.33 million in taxes.
| Income Tax | 9.33M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -47.15% in the last 52 weeks. The beta is 1.56, so MD's price volatility has been higher than the market average.
| Beta (5Y) | 1.56 |
| 52-Week Price Change | -47.15% |
| 50-Day Moving Average | 7.47 |
| 200-Day Moving Average | 9.14 |
| Relative Strength Index (RSI) | 52.15 |
| Average Volume (20 Days) | 1,595,893 |
Short Selling Information
The latest short interest is 5.44 million, so 6.46% of the outstanding shares have been sold short.
| Short Interest | 5.44M |
| Short Previous Month | 5.54M |
| Short % of Shares Out | 6.46% |
| Short % of Float | 6.69% |
| Short Ratio (days to cover) | 2.42 |
Income Statement
In the last 12 months, MD had revenue of $2.00 billion and -$70.58 million in losses. Loss per share was -$0.85.
| Revenue | 2.00B |
| Gross Profit | 418.39M |
| Operating Income | -6.83M |
| Pretax Income | -61.25M |
| Net Income | -70.58M |
| EBITDA | 18.56M |
| EBIT | -18.96M |
| Loss Per Share | -$0.85 |
Balance Sheet
The company has $115.47 million in cash and $778.66 million in debt, giving a net cash position of -$663.19 million or -$7.88 per share.
| Cash & Cash Equivalents | 115.47M |
| Total Debt | 778.66M |
| Net Cash | -663.19M |
| Net Cash Per Share | -$7.88 |
| Equity (Book Value) | 856.20M |
| Book Value Per Share | 10.17 |
| Working Capital | 179.24M |
Cash Flow
In the last 12 months, operating cash flow was $113.02 million and capital expenditures -$31.66 million, giving a free cash flow of $81.36 million.
| Operating Cash Flow | 113.02M |
| Capital Expenditures | -31.66M |
| Free Cash Flow | 81.36M |
| FCF Per Share | $0.98 |
Margins
Gross margin is 20.93%, with operating and profit margins of -0.34% and -3.53%.
| Gross Margin | 20.93% |
| Operating Margin | -0.34% |
| Pretax Margin | -3.06% |
| Profit Margin | -3.53% |
| EBITDA Margin | 0.93% |
| EBIT Margin | -0.95% |
| FCF Margin | 4.07% |
Dividends & Yields
MD does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.16% |
| Shareholder Yield | -1.16% |
| Earnings Yield | -11.15% |
| FCF Yield | 12.86% |
Analyst Forecast
The average price target for MD is $8.70, which is 15.69% higher than the current price. The consensus rating is "Hold".
| Price Target | $8.70 |
| Price Target Difference | 15.69% |
| Analyst Consensus | Hold |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on December 20, 2013. It was a forward split with a ratio of 2:1.
| Last Split Date | Dec 20, 2013 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
MD has an Altman Z-Score of 1.19 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.19 |
| Piotroski F-Score | 5 |